A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer

Gynecologic Oncology

Volumn 95, Issue 2, 2004, Pages 347-351

  Downs Jr , Levi S ^a   Judson, Patricia L ^a   Argenta, Peter A ^a   Carson, Linda F ^a   Boente, Matthew P ^a  

^a Department of Obstetrics   (United States)

Author keywords

Carboplatin; Cervical cancer; Ifosmide; Paclitel

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; IFOSFAMIDE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; HUMAN; MAXIMUM TOLERATED DOSE; MUSCLE WEAKNESS; MYALGIA; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; SIDE EFFECT; THROMBOCYTOPENIA; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AMBULATORY CARE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IFOSFAMIDE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; UTERINE CERVICAL NEOPLASMS;

EID: 7444259652     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.07.037     Document Type: Article

References (23)

1. Cancer Facts and Figures - 2004 2004 American Cancer Society Atlanta, GA 1 60
2. E.L. Franco, N.F. Schlecht, and D. Saslow The epidemiology of cervical cancer Cancer J. 9 2003 348 359
3. S.E. Waggoner Cervical cancer Lancet 361 2003 2217 2225
4. G.A. Omura, J.A. Blessing, and L. Vaccarello Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a gynecologic oncology group study J. Clin. Oncol. 15 1997 165 171
5. G.R. Weiss, S. Green, and E.V. Hannigah A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a southwest oncology group study Gynecol. Oncol. 39 1990 332 336
6. P. Bonomi, J. Blessing, and F.B. Stehman Cisplatin in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the gynecologic oncology group Cancer 48 1981 899 903
7. W.P. McGuire, J.A. Blessing, S.S. Lentz, and G. Photopulous Paclitaxel has moderate activity in squamous cervix cancer: a gynecologic oncology group study J. Clin. Oncol. 14 1996 792 795
8. D.H. Moore, R.P. McQuellon, and J.A. Blessing A randomized phase III study of cisplatin versus cisplatin plus paclitaxel in stage IVB recurrent or persistent squamous cell carcinoma of the cervix Gynecol. Oncol. 80 2001 276
9. B.M. Shin, B.S. Glisson, and F.R. Khuri Phase II trial of paclitaxel, ifosfamide and cisplatin in patients with recurrent head and neck squamous cell carcinoma J. Clin. Oncol. 16 1998 1325 1330
10. D.F. Bajorin, J.A. McCaffery, and S. Hilton Treatment of patients with transitional-cell carcinoma of the urothelial tract with Ifosfamide, paclitaxel and cisplatin: a phase II trial J. Clin. Oncol. 16 1998 2722 2727
11. D.M. Shin, F.R. Khuri, and B.S. Glisson Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma Cancer 91 2000 1316 1323
12. A.R. Padhani, and L. Ollivier The RECIST (Response Evaluation Criteria in Solid Tumors) criteria: implications for diagnostic radiologists Br. J. Radiol. 74 887 2001 (Nov.) 983 986
13. D.F. Cella, D.S. Tulsky, and G. Gary The functional assessment of cancer therapy scale: development and validation of the general measure J. Clin. Oncol. 11 1993 570 579
14. D.F. Cella Manual for the Functional Assessment of Cancer Therapy (FACT) Measurement System (version 3) 1994 Rush Cancer Center Chicago
15. A.M. Mauer, R.H. Ansari, and P.C. Hoffman Phase I/II investigation of paclitaxel, ifosfamide and carboplatin for advanced non-small-cell lung cancer Ann. Oncol. 14 5 2003 (May) 722 788
16. M.A. Socinski, M.A. Neubauer, and J. Olivares Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer Lung Cancer 40 1 2003 (April) 91 97
17. D.M. Shin, B.S. Glisson, and F.R. Khuri Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck Cancer 95 2002 322 330
18. G. Zanetta, A. Lissoni, and A. Pellegrino Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer Ann. Oncol. 9 1998 977 980
19. G. Zanetta, F. Fei, G. Parma, M. Balestrino, A. Lissoni, A. Gabriele, and C. Mangioni Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer Ann. Oncol. 10 1999 1171 1174
20. M.A. Dimopoulos, C.A. Papadimitriou, and K. Sarris Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group Gynecol. Oncol. 85 2002 476 482
21. T. Thigpen, R.B. Vance, and T. Khansur The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix Semin. Oncol. 22 Suppl. 12 1995 67 75
22. R.C. Park, and T. Thigpen Chemotherapy in advanced and recurrent cervical cancer Cancer 71 1993 1446 1450
23. J.B. Vermorken The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review Int. J. Gynecol. Cancer 3 1993 129 142